Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set
Joanna Tieu(Royal Adelaide Hospital), Catherine Hill(Royal Adelaide Hospital), Andrea Hinojosa‐Azaola(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Rachel Black(The University of Sydney), Maarten de Witt(National Patient Safety Foundation), I. Z. Gaydukova(North-Western State Medical University named after I.I. Mechnikov), Robin Christensen(University of Copenhagen), Karine Toupin‐April(Children's Hospital of Eastern Ontario), Peter Tugwell(University of Ottawa), Lauren King(University of Toronto), Oscar Russell(Queen Elizabeth Hospital), Marco A Alba Garibay(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Susan M. Goodman(Hospital for Special Surgery), Corrado Campochiaro(Vita-Salute San Raffaele University), Joanna Robson(University of the West of England), Maarten Boers(Amsterdam University Medical Centers), Kevin Yip(Hospital for Special Surgery), Suellen Anne Lyne(Flinders Medical Centre), Chetan Mukhtyar(Norfolk and Norwich University Hospitals NHS Foundation Trust), Nilasha Ghosh(Hospital for Special Surgery), Michael George(University of Pennsylvania), Huai Leng Pisaniello(Basil Hetzel Institute), Beverley Shea(University of Ottawa), Courage Uhunmwangho(University of Jos), Simon Décary(Université de Sherbrooke), Win Min Oo(The University of Sydney), Sebastian E. Sattui(University of Pittsburgh), Anthony P. Fernandez(Cleveland Clinic), Jasvinder A Singhi(University of Alabama at Birmingham), Helen Keen(The University of Western Australia), Michelle Petri(Johns Hopkins University), Lee S. Simon(Norfolk and Norwich University Hospital), C. Richard Hofstetter(National Patient Safety Foundation), Ashima Makol(Mayo Clinic), Margaret T. Whitstock(National Patient Safety Foundation), Jonathan TL. Cheah(UMass Memorial Health Care), Pamela Richards(National Patient Safety Foundation), Latika Gupta(The Francis Crick Institute), Sarah Mackie(Leeds Teaching Hospitals NHS Trust), Vítor Teixeira(Algarve Biomedical Center)
Cited by 12
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
|Annals of the Rheumatic Diseases|2016|1.2k
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k